Tenbin Labs | $7,000,000 | (Jan 29, 2026)
Yolando | $8,500,000 | (Jan 29, 2026)
Ricursive Intelligence | $300,000,000 | (Jan 28, 2026)
Rapport Therapeutics
United States
- Boston, Massachusetts
- 08/03/2023
- Series A
- $100,000,000
Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.
- Industry Biotechnology Research
- Website https://www.rapportrx.com/
- LinkedIn https://www.linkedin.com/company/rapport-therapeutics/
Jelou AI | $10,000,000 | (Jan 28, 2026)
Concourse | $12,000,000 | (Jan 28, 2026)
Summize | $50,000,000 | (Jan 28, 2026)
Fortitude Biomedicines | $13,000,000 | (Jan 28, 2026)
Fiddler AI | $30,000,000 | (Jan 28, 2026)
Chamelio | $10,000,000 | (Jan 28, 2026)
Opendate | $14,000,000 | (Jan 28, 2026)
Nerd Apply | $3,200,000 | (Jan 28, 2026)
Memcyco | $37,000,000 | (Jan 28, 2026)
Midship | $4,150,000 | (Jan 28, 2026)